Resonance Specialties（524218）株式概要レゾナンス・スペシャリティーズ社は、インド国内および海外で特殊化学品の製造・販売を行っている。 詳細524218 ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績4/6財務の健全性5/6配当金4/6報酬当社が推定した公正価値より82.3%で取引されている 過去1年間で収益は58.3%増加しました リスク分析過去5年間で収益は年間14.9%減少しました。 意味のある時価総額がありません ( ₹2B )不安定な配当実績 すべてのリスクチェックを見る524218 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹138.5557.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-8m1b2016201920222025202620282031Revenue ₹1.0bEarnings ₹118.8mAdvancedSet Fair ValueView all narrativesResonance Specialties Limited 競合他社Patel Chem SpecialitiesSymbol: BSE:544460Market cap: ₹2.3bSPEB AdhesivesSymbol: NSEI:SPEBMarket cap: ₹1.9bHindprakash IndustriesSymbol: NSEI:HPILMarket cap: ₹1.5bSrivasavi Adhesive TapesSymbol: NSEI:SRIVASAVIMarket cap: ₹948.3m価格と性能株価の高値、安値、推移の概要Resonance Specialties過去の株価現在の株価₹138.5552週高値₹147.4552週安値₹77.00ベータ0.361ヶ月の変化8.68%3ヶ月変化54.20%1年変化18.62%3年間の変化61.10%5年間の変化-7.08%IPOからの変化9,136.67%最新ニュースDeclared Dividend • May 16Dividend of ₹1.00 announcedDividend of ₹1.00 is the same as last year. Ex-date: 28th July 2026 Payment date: 1st January 1970 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (18% earnings payout ratio) and cash flows (9% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.お知らせ • May 15Resonance Specialties Limited announces Annual dividendResonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 28, 2026 and record date on July 28, 2026.お知らせ • May 02Resonance Specialties Limited to Report Q4, 2026 Results on May 14, 2026Resonance Specialties Limited announced that they will report Q4, 2026 results on May 14, 2026New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.01b market cap, or US$10.8m).Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹77.93, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years.New Risk • Mar 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$9.50m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹899.6m market cap, or US$9.50m). Minor Risk Paying a dividend despite having no free cash flows.最新情報をもっと見るRecent updatesDeclared Dividend • May 16Dividend of ₹1.00 announcedDividend of ₹1.00 is the same as last year. Ex-date: 28th July 2026 Payment date: 1st January 1970 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (18% earnings payout ratio) and cash flows (9% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.お知らせ • May 15Resonance Specialties Limited announces Annual dividendResonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 28, 2026 and record date on July 28, 2026.お知らせ • May 02Resonance Specialties Limited to Report Q4, 2026 Results on May 14, 2026Resonance Specialties Limited announced that they will report Q4, 2026 results on May 14, 2026New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.01b market cap, or US$10.8m).Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹77.93, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years.New Risk • Mar 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$9.50m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹899.6m market cap, or US$9.50m). Minor Risk Paying a dividend despite having no free cash flows.Board Change • Mar 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Non-Executive Non- Independent Director Nilesh Jain was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: ₹2.18 (vs ₹0.96 in 3Q 2025)Third quarter 2026 results: EPS: ₹2.18 (up from ₹0.96 in 3Q 2025). Revenue: ₹232.9m (up 28% from 3Q 2025). Net income: ₹25.1m (up 125% from 3Q 2025). Profit margin: 11% (up from 6.1% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹108, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 11% over the past three years.お知らせ • Jan 13Resonance Specialties Limited to Report Q3, 2026 Results on Feb 04, 2026Resonance Specialties Limited announced that they will report Q3, 2026 results on Feb 04, 2026Reported Earnings • Nov 04Second quarter 2026 earnings released: EPS: ₹1.44 (vs ₹1.55 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.44 (down from ₹1.55 in 2Q 2025). Revenue: ₹218.9m (up 21% from 2Q 2025). Net income: ₹16.6m (down 8.2% from 2Q 2025). Profit margin: 7.6% (down from 10.0% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.お知らせ • Oct 15Resonance Specialties Limited to Report Q2, 2026 Results on Nov 03, 2025Resonance Specialties Limited announced that they will report Q2, 2026 results on Nov 03, 2025Upcoming Dividend • Jul 22Upcoming dividend of ₹1.00 per shareEligible shareholders must have bought the stock before 29 July 2025. Payment date: 29 August 2025. Payout ratio is a comfortable 18% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).お知らせ • Jul 21Resonance Specialties Limited to Report Q1, 2026 Results on Aug 05, 2025Resonance Specialties Limited announced that they will report Q1, 2026 results on Aug 05, 2025Reported Earnings • Jul 11Full year 2025 earnings released: EPS: ₹5.69 (vs ₹2.57 in FY 2024)Full year 2025 results: EPS: ₹5.69 (up from ₹2.57 in FY 2024). Revenue: ₹778.1m (up 41% from FY 2024). Net income: ₹65.7m (up 121% from FY 2024). Profit margin: 8.4% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Jul 02Resonance Specialties Limited, Annual General Meeting, Aug 05, 2025Resonance Specialties Limited, Annual General Meeting, Aug 05, 2025, at 12:30 Indian Standard Time.New Risk • May 25New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 17% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹1.35b market cap, or US$15.9m).お知らせ • May 20Resonance Specialties Limited announces Annual dividendResonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 29, 2025 and record date on July 29, 2025.New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.02b market cap, or US$11.9m).Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 34%After last week's 34% share price gain to ₹106, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹67.77, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 61% over the past three years.New Risk • Mar 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹821.8m (US$9.59m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Market cap is less than US$10m (₹821.8m market cap, or US$9.59m).Reported Earnings • Jan 25Third quarter 2025 earnings released: EPS: ₹0.96 (vs ₹0.83 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.96 (up from ₹0.83 in 3Q 2024). Revenue: ₹185.4m (up 21% from 3Q 2024). Net income: ₹11.2m (up 16% from 3Q 2024). Profit margin: 6.0% (down from 6.3% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.お知らせ • Jan 08Resonance Specialties Limited to Report Q3, 2025 Results on Jan 24, 2025Resonance Specialties Limited announced that they will report Q3, 2025 results on Jan 24, 2025Reported Earnings • Oct 24Second quarter 2025 earnings released: EPS: ₹1.55 (vs ₹0.39 in 2Q 2024)Second quarter 2025 results: EPS: ₹1.55 (up from ₹0.39 in 2Q 2024). Revenue: ₹184.0m (up 81% from 2Q 2024). Net income: ₹18.1m (up 290% from 2Q 2024). Profit margin: 9.8% (up from 4.6% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹110, the stock trades at a trailing P/E ratio of 47.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.お知らせ • Oct 09Resonance Specialties Limited to Report Q2, 2025 Results on Oct 23, 2024Resonance Specialties Limited announced that they will report Q2, 2025 results on Oct 23, 2024お知らせ • Jul 22Resonance Specialties Limited to Report Q1, 2025 Results on Aug 02, 2024Resonance Specialties Limited announced that they will report Q1, 2025 results on Aug 02, 2024Reported Earnings • Jul 09Full year 2024 earnings released: EPS: ₹2.57 (vs ₹4.33 in FY 2023)Full year 2024 results: EPS: ₹2.57 (down from ₹4.33 in FY 2023). Revenue: ₹553.0m (down 6.0% from FY 2023). Net income: ₹29.7m (down 41% from FY 2023). Profit margin: 5.4% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.お知らせ • Jul 04Resonance Specialties Limited, Annual General Meeting, Aug 02, 2024Resonance Specialties Limited, Annual General Meeting, Aug 02, 2024, at 15:00 Indian Standard Time.Reported Earnings • May 16Full year 2024 earnings released: EPS: ₹2.56 (vs ₹4.33 in FY 2023)Full year 2024 results: EPS: ₹2.56 (down from ₹4.33 in FY 2023). Revenue: ₹562.3m (down 4.4% from FY 2023). Net income: ₹29.7m (down 41% from FY 2023). Profit margin: 5.3% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.お知らせ • May 08Resonance Specialties Limited to Report Q4, 2024 Results on May 14, 2024Resonance Specialties Limited announced that they will report Q4, 2024 results on May 14, 2024Valuation Update With 7 Day Price Move • Apr 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹109, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: ₹0.83 (vs ₹0.75 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.83 (up from ₹0.75 in 3Q 2023). Revenue: ₹156.0m (up 69% from 3Q 2023). Net income: ₹9.61m (up 11% from 3Q 2023). Profit margin: 6.2% (down from 9.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Jan 19Resonance Specialties Limited to Report Nine Months, 2024 Results on Feb 06, 2024Resonance Specialties Limited announced that they will report nine months, 2024 results on Feb 06, 2024Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹112, the stock trades at a trailing P/E ratio of 37.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years.Reported Earnings • Nov 04Second quarter 2024 earnings released: EPS: ₹0.39 (vs ₹1.24 in 2Q 2023)Second quarter 2024 results: EPS: ₹0.39 (down from ₹1.24 in 2Q 2023). Revenue: ₹103.9m (down 31% from 2Q 2023). Net income: ₹4.63m (down 66% from 2Q 2023). Profit margin: 4.5% (down from 9.1% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.お知らせ • Oct 19Resonance Specialties Limited to Report Q2, 2024 Results on Nov 03, 2023Resonance Specialties Limited announced that they will report Q2, 2024 results on Nov 03, 2023お知らせ • Aug 30Resonance Specialties Limited Approves Appointment of Vaibhavi Rajeshirke as Company Secretary & Compliance OfficerResonance Specialties Limited announced that at its board meeting held on August 30, 2023, the Board has appointed Ms. Vaibhavi Rajeshirke as the company secretary & compliance officer and nodal officer for IEPF of the company with effect from August 30, 2023. Ms. Vaibhavi Rajeshirke, aged 29 years is a post graduate in commerce (M.COM) and is also an Associate Member of the Institute of Company Secretaries of India, Membership no ACS 72229. She has nearly 2 years experience in the field of Compliances and Company Secretarial functions.Upcoming Dividend • Jul 25Upcoming dividend of ₹1.00 per share at 1.1% yieldEligible shareholders must have bought the stock before 01 August 2023. Payment date: 07 September 2023. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%).お知らせ • Jul 24Resonance Specialties Limited to Report Q1, 2024 Results on Aug 08, 2023Resonance Specialties Limited announced that they will report Q1, 2024 results on Aug 08, 2023お知らせ • Jul 12Resonance Specialties Limited Recommends Dividend for the Financial Year Ended March 31, 2023, Payable on or Before August 31, 2023The Board of Resonance Specialties Limited has recommended a dividend of INR 1 per share (10%) for the financial year ended 31st March, 2023 on its equity shares of face value of INR 10 each which if sanctioned will be paid on or before August 31, 2023.Reported Earnings • Jul 12Full year 2023 earnings released: EPS: ₹4.33 (vs ₹10.71 in FY 2022)Full year 2023 results: EPS: ₹4.33 (down from ₹10.71 in FY 2022). Revenue: ₹588.1m (down 22% from FY 2022). Net income: ₹50.0m (down 60% from FY 2022). Profit margin: 8.5% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 06Resonance Specialties Limited, Annual General Meeting, Aug 08, 2023Resonance Specialties Limited, Annual General Meeting, Aug 08, 2023, at 15:30 Indian Standard Time.Reported Earnings • May 15Full year 2023 earnings released: EPS: ₹4.37 (vs ₹10.71 in FY 2022)Full year 2023 results: EPS: ₹4.37 (down from ₹10.71 in FY 2022). Revenue: ₹604.3m (down 20% from FY 2022). Net income: ₹50.0m (down 60% from FY 2022). Profit margin: 8.3% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 12Resonance Specialties Limited Proposes Dividend for the Financial Year 2022-23Resonance Specialties Limited at its board of directors meeting held on May 11, 2023 declared a dividend of INR 1 per share (10%) for the financial year 2022-23 subject to the approval of the Shareholders at the forthcoming Annual General Meeting.Buying Opportunity • Feb 27Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be ₹129, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Earnings per share has grown by 13%.Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹0.75 (vs ₹2.51 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.75 (down from ₹2.51 in 3Q 2022). Revenue: ₹93.9m (down 46% from 3Q 2022). Net income: ₹8.70m (down 70% from 3Q 2022). Profit margin: 9.3% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 25Resonance Specialties Limited to Report Q3, 2023 Results on Feb 02, 2023Resonance Specialties Limited announced that they will report Q3, 2023 results on Feb 02, 2023Board Change • Nov 16High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: ₹1.24 (vs ₹2.99 in 2Q 2022)Second quarter 2023 results: EPS: ₹1.24 (down from ₹2.99 in 2Q 2022). Revenue: ₹158.2m (down 14% from 2Q 2022). Net income: ₹13.8m (down 59% from 2Q 2022). Profit margin: 8.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 10+ 1 more updateResonance Specialties Limited Announces Resignation of Ashish Katariya as CEOResonance Specialties Limited announced resignation of Ashish Katariya as CEO of the Company due to personal reasons and his resignation is accepted by the Board with effect from close of business hours of the Company on 9th November, 2022.お知らせ • Nov 02Resonance Specialties Limited to Report Q2, 2023 Results on Nov 09, 2022Resonance Specialties Limited announced that they will report Q2, 2023 results on Nov 09, 2022Buying Opportunity • Aug 29Now 23% undervaluedOver the last 90 days, the stock is up 5.6%. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 35%.Buying Opportunity • Aug 14Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be ₹206, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 35%.お知らせ • Aug 03Resonance Specialties Limited to Report Q1, 2023 Results on Aug 11, 2022Resonance Specialties Limited announced that they will report Q1, 2023 results on Aug 11, 2022Board Change • Aug 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Upcoming Dividend • Jul 28Upcoming dividend of ₹1.00 per shareEligible shareholders must have bought the stock before 04 August 2022. Payment date: 09 September 2022. Payout ratio is a comfortable 9.3% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.8%). Lower than average of industry peers (0.8%).Reported Earnings • Jul 17Full year 2022 earnings released: EPS: ₹10.64 (vs ₹9.12 in FY 2021)Full year 2022 results: EPS: ₹10.64 (up from ₹9.12 in FY 2021). Revenue: ₹771.1m (up 8.8% from FY 2021). Net income: ₹123.6m (up 17% from FY 2021). Profit margin: 16% (up from 15% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹166, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 326% over the past three years.お知らせ • Jun 23Resonance Specialties Limited, Annual General Meeting, Aug 11, 2022Resonance Specialties Limited, Annual General Meeting, Aug 11, 2022. Agenda: To consider approval of dividend; to consider appointment of Mr. Charchit Jain as an Additional and Whole-time Director of the Company; and to consider other matters.お知らせ • May 12+ 1 more updateResonance Specialties Limited Announces Resignation of Dwarika Agrawal as Whole-Time DirectorResonance Specialties Limited announced that at its Board Meeting held on May 11, 2022, Mr. Dwarika Agrawal has resigned as a Whole-time Director of the Company and is under Notice period.お知らせ • May 05Resonance Specialties Limited to Report Q4, 2022 Results on May 11, 2022Resonance Specialties Limited announced that they will report Q4, 2022 results on May 11, 2022Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹218, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 743% over the past three years.Reported Earnings • Oct 28Second quarter 2022 earnings released: EPS ₹2.99 (vs ₹3.44 in 2Q 2021)The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹189.4m (down 17% from 2Q 2021). Net income: ₹33.5m (down 16% from 2Q 2021). Profit margin: 18% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 105% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 13Investor sentiment improved over the past weekAfter last week's 31% share price gain to ₹229, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 797% over the past three years.Upcoming Dividend • Aug 11Upcoming dividend of ₹1.00 per shareEligible shareholders must have bought the stock before 18 August 2021. Payment date: 25 September 2021. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.7%).Reported Earnings • Aug 05Full year 2021 earnings released: EPS ₹9.12 (vs ₹4.77 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹709.0m (up 24% from FY 2020). Net income: ₹105.2m (up 91% from FY 2020). Profit margin: 15% (up from 9.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 17Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹172, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 740% over the past three years.Reported Earnings • Jun 05Full year 2021 earnings released: EPS ₹8.78 (vs ₹4.77 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹718.7m (up 25% from FY 2020). Net income: ₹105.2m (up 91% from FY 2020). Profit margin: 15% (up from 9.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 81% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • May 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹154, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 509% over the past three years.Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹142, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 357% over the past three years.Reported Earnings • Feb 07Third quarter 2021 earnings released: EPS ₹2.82 (vs ₹2.09 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹187.5m (up 11% from 3Q 2020). Net income: ₹36.3m (up 50% from 3Q 2020). Profit margin: 19% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 03New 90-day high: ₹158The company is up 166% from its price of ₹59.35 on 05 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.お知らせ • Jan 25Resonance Specialties Limited to Report Q3, 2021 Results on Feb 05, 2021Resonance Specialties Limited announced that they will report Q3, 2021 results on Feb 05, 2021Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹154, the stock is trading at a trailing P/E ratio of 21.5x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 19x in the Chemicals industry in India. Total returns to shareholders over the past three years are 323%.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹135, the stock is trading at a trailing P/E ratio of 18.7x, up from the previous P/E ratio of 16.2x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 217%.お知らせ • Dec 23+ 1 more updateResonance Specialties Limited Announces CEO ChangesResonance Specialties Limited at its board meeting held on December 21, 2020, announced that Dr. Atma Bandhu Gupta, Managing Director has informed the Company of his inability to continue as Managing Director and his intention to resign as Managing Director of the Company due to his pre-occupation and other personal reasons vide his letter dated December 14, 2020. Accordingly, the Board of Directors at their meeting held on December 21, 2020, have accepted his resignation as a Managing Director /Director of the Company with immediate effect. Mr. Ashish Katariya, Executive Director of the Company is appointed as the CEO of the Company. .Valuation Update With 7 Day Price Move • Dec 15Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹105, the stock is trading at a trailing P/E ratio of 14.7x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 245%.Is New 90 Day High Low • Dec 15New 90-day high: ₹105The company is up 72% from its price of ₹61.15 on 15 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.お知らせ • Nov 20Resonance Specialties Limited Announces Board ChangesResonance Specialties Limited announced that the appointment of Mr. Raj Kamal Prasad Verma as an Additional Director (Non-Executive & Independent), on the board of directors of Resonance Specialties Limited, it has been resolved to reconstitute Audit Committee of the Company and accordingly the Board of Directors of the Company vide Circular resolution dated November 18, 2020, have approved and reconstituted the following Committees of the Board with immediate effect: The audit committee is appointed Ms. Archana Surendra Yadav as chairman, Mr. Raj Kamal Prasad Verma, Mr. Bishwanath Prasad Agrawal and Mr. Ajay Patadia as members. The nomination and remuneration committee is appointed Mr. Raj Kamal Prasad Verma as chairman, Ms. Archana Surendra Yadav, Mr. Bishwanath Prasad Agrawal and Mr. Ajay Patadia as members. Stakeholders Relationship Committee is appointed Mr. Bishwanath Prasad Agrawal as chairman, Ms. Archana Surendra Yadav, Mr. Atma Bandhu Gupta and Mr. Raj Kamal Prasad Verma as members. Corporate Social Responsibility Committee is appointed Mr. Atma Bandhu Gupta as chairman, Mr. Bishwanath Prasad Agrawal, Ms. Archana Surendra Yadav and Mr. Raj Kamal Prasad Verma as members.Reported Earnings • Nov 13Second quarter 2021 earnings released: EPS ₹3.44The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹227.6m (up 68% from 2Q 2020). Net income: ₹39.8m (up 254% from 2Q 2020). Profit margin: 18% (up from 8.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 18% share price gain to ₹69.85, the stock is trading at a trailing P/E ratio of 15x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 129%.Is New 90 Day High Low • Nov 12New 90-day high: ₹69.85The company is up 49% from its price of ₹46.80 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.お知らせ • Sep 09Resonance Specialties Limited to Report Q1, 2021 Results on Sep 15, 2020Resonance Specialties Limited announced that they will report Q1, 2021 results on Sep 15, 2020お知らせ • Aug 08Resonance Specialties Limited Expects to Full Plant Operations in Couple of MonthsResonance Specialties Limited announced that due to COVID-19 outbreak and as per directives issued by the Government of India, State Governments and other regulatory authorities, the company had temporarily suspended manufacturing in company's Plant. Operations were partially resumed and full resumption is expected in next couple of months. The Company has also Implemented Work from Home Policy for its employees to ensure compliance with Government's directives and to safeguard employee's health and safety.お知らせ • Jul 05Resonance Specialties Limited to Report Q4, 2020 Results on Jul 31, 2020Resonance Specialties Limited announced that they will report Q4, 2020 results on Jul 31, 2020株主還元524218IN ChemicalsIN 市場7D-2.5%0.3%0.6%1Y18.6%-2.3%-0.2%株主還元を見る業界別リターン: 524218過去 1 年間で-2.3 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 524218過去 1 年間で-0.2 % の収益を上げたIndian市場を上回りました。価格変動Is 524218's price volatile compared to industry and market?524218 volatility524218 Average Weekly Movement7.9%Chemicals Industry Average Movement7.1%Market Average Movement7.0%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.5%安定した株価: 524218 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 524218の 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト198966Charchit Jainwww.resonancesl.comレゾナンス・スペシャルティーズ社は、インド国内外で特殊化学品の製造・販売を行っている。農薬、医薬品、原薬、染料、ゴム薬品などの製造に使用されるピリジン、ナイアシンアミドの製造に使用されるシアノピリジン、ビニルラテックスゴム、ビタミンB3、抗結核薬の製造に使用されるα、β、γピコリンなどのピコリンを提供。また、ピコリン酸亜鉛、ピコリン酸クロム、ポリニコチン酸クロム、ナイアシン、ナイアシンアミド、イソニアジドなどの栄養剤、αピコリン酸、ジピコリン酸、アセトニトリル、バレロニトリルなどの溶剤、抗潰瘍剤用ルチジン、オメプラゾール、ランソプラゾール、レバプラゾール、エソメプラゾールなどのコリジンも提供している。前身はアーマー・ポリマーズ社。レゾナンス・スペシャリティーズ社は1989年に設立され、インドのムンバイに本社を置く。もっと見るResonance Specialties Limited 基礎のまとめResonance Specialties の収益と売上を時価総額と比較するとどうか。524218 基礎統計学時価総額₹1.54b収益（TTM）₹103.96m売上高(TTM)₹902.48m15.4xPER（株価収益率1.8xP/Sレシオ524218 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計524218 損益計算書（TTM）収益₹902.48m売上原価₹563.35m売上総利益₹339.13mその他の費用₹235.17m収益₹103.96m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）9.01グロス・マージン37.58%純利益率11.52%有利子負債／自己資本比率2.8%524218 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.7%現在の配当利回り11%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/24 21:30終値2026/06/24 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Resonance Specialties Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Declared Dividend • May 16Dividend of ₹1.00 announcedDividend of ₹1.00 is the same as last year. Ex-date: 28th July 2026 Payment date: 1st January 1970 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (18% earnings payout ratio) and cash flows (9% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.
お知らせ • May 15Resonance Specialties Limited announces Annual dividendResonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 28, 2026 and record date on July 28, 2026.
お知らせ • May 02Resonance Specialties Limited to Report Q4, 2026 Results on May 14, 2026Resonance Specialties Limited announced that they will report Q4, 2026 results on May 14, 2026
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.01b market cap, or US$10.8m).
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹77.93, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years.
New Risk • Mar 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$9.50m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹899.6m market cap, or US$9.50m). Minor Risk Paying a dividend despite having no free cash flows.
Declared Dividend • May 16Dividend of ₹1.00 announcedDividend of ₹1.00 is the same as last year. Ex-date: 28th July 2026 Payment date: 1st January 1970 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (18% earnings payout ratio) and cash flows (9% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has remained steady over the last 5 years. Unless this trend deteriorates, it should provide adequate earnings cover for the dividend.
お知らせ • May 15Resonance Specialties Limited announces Annual dividendResonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 28, 2026 and record date on July 28, 2026.
お知らせ • May 02Resonance Specialties Limited to Report Q4, 2026 Results on May 14, 2026Resonance Specialties Limited announced that they will report Q4, 2026 results on May 14, 2026
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₹1.01b market cap, or US$10.8m).
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹77.93, the stock trades at a trailing P/E ratio of 10.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 1.8% over the past three years.
New Risk • Mar 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$9.50m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (₹899.6m market cap, or US$9.50m). Minor Risk Paying a dividend despite having no free cash flows.
Board Change • Mar 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Non-Executive Non- Independent Director Nilesh Jain was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: ₹2.18 (vs ₹0.96 in 3Q 2025)Third quarter 2026 results: EPS: ₹2.18 (up from ₹0.96 in 3Q 2025). Revenue: ₹232.9m (up 28% from 3Q 2025). Net income: ₹25.1m (up 125% from 3Q 2025). Profit margin: 11% (up from 6.1% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹108, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 11% over the past three years.
お知らせ • Jan 13Resonance Specialties Limited to Report Q3, 2026 Results on Feb 04, 2026Resonance Specialties Limited announced that they will report Q3, 2026 results on Feb 04, 2026
Reported Earnings • Nov 04Second quarter 2026 earnings released: EPS: ₹1.44 (vs ₹1.55 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.44 (down from ₹1.55 in 2Q 2025). Revenue: ₹218.9m (up 21% from 2Q 2025). Net income: ₹16.6m (down 8.2% from 2Q 2025). Profit margin: 7.6% (down from 10.0% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
お知らせ • Oct 15Resonance Specialties Limited to Report Q2, 2026 Results on Nov 03, 2025Resonance Specialties Limited announced that they will report Q2, 2026 results on Nov 03, 2025
Upcoming Dividend • Jul 22Upcoming dividend of ₹1.00 per shareEligible shareholders must have bought the stock before 29 July 2025. Payment date: 29 August 2025. Payout ratio is a comfortable 18% but the company is not cash flow positive. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).
お知らせ • Jul 21Resonance Specialties Limited to Report Q1, 2026 Results on Aug 05, 2025Resonance Specialties Limited announced that they will report Q1, 2026 results on Aug 05, 2025
Reported Earnings • Jul 11Full year 2025 earnings released: EPS: ₹5.69 (vs ₹2.57 in FY 2024)Full year 2025 results: EPS: ₹5.69 (up from ₹2.57 in FY 2024). Revenue: ₹778.1m (up 41% from FY 2024). Net income: ₹65.7m (up 121% from FY 2024). Profit margin: 8.4% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Jul 02Resonance Specialties Limited, Annual General Meeting, Aug 05, 2025Resonance Specialties Limited, Annual General Meeting, Aug 05, 2025, at 12:30 Indian Standard Time.
New Risk • May 25New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 17% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹1.35b market cap, or US$15.9m).
お知らせ • May 20Resonance Specialties Limited announces Annual dividendResonance Specialties Limited announced Annual dividend of INR 1.0000 per share, ex-date on July 29, 2025 and record date on July 29, 2025.
New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.02b market cap, or US$11.9m).
Valuation Update With 7 Day Price Move • May 19Investor sentiment improves as stock rises 34%After last week's 34% share price gain to ₹106, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹67.77, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 61% over the past three years.
New Risk • Mar 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹821.8m (US$9.59m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 17% per year over the past 5 years. Market cap is less than US$10m (₹821.8m market cap, or US$9.59m).
Reported Earnings • Jan 25Third quarter 2025 earnings released: EPS: ₹0.96 (vs ₹0.83 in 3Q 2024)Third quarter 2025 results: EPS: ₹0.96 (up from ₹0.83 in 3Q 2024). Revenue: ₹185.4m (up 21% from 3Q 2024). Net income: ₹11.2m (up 16% from 3Q 2024). Profit margin: 6.0% (down from 6.3% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 08Resonance Specialties Limited to Report Q3, 2025 Results on Jan 24, 2025Resonance Specialties Limited announced that they will report Q3, 2025 results on Jan 24, 2025
Reported Earnings • Oct 24Second quarter 2025 earnings released: EPS: ₹1.55 (vs ₹0.39 in 2Q 2024)Second quarter 2025 results: EPS: ₹1.55 (up from ₹0.39 in 2Q 2024). Revenue: ₹184.0m (up 81% from 2Q 2024). Net income: ₹18.1m (up 290% from 2Q 2024). Profit margin: 9.8% (up from 4.6% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹110, the stock trades at a trailing P/E ratio of 47.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.
お知らせ • Oct 09Resonance Specialties Limited to Report Q2, 2025 Results on Oct 23, 2024Resonance Specialties Limited announced that they will report Q2, 2025 results on Oct 23, 2024
お知らせ • Jul 22Resonance Specialties Limited to Report Q1, 2025 Results on Aug 02, 2024Resonance Specialties Limited announced that they will report Q1, 2025 results on Aug 02, 2024
Reported Earnings • Jul 09Full year 2024 earnings released: EPS: ₹2.57 (vs ₹4.33 in FY 2023)Full year 2024 results: EPS: ₹2.57 (down from ₹4.33 in FY 2023). Revenue: ₹553.0m (down 6.0% from FY 2023). Net income: ₹29.7m (down 41% from FY 2023). Profit margin: 5.4% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
お知らせ • Jul 04Resonance Specialties Limited, Annual General Meeting, Aug 02, 2024Resonance Specialties Limited, Annual General Meeting, Aug 02, 2024, at 15:00 Indian Standard Time.
Reported Earnings • May 16Full year 2024 earnings released: EPS: ₹2.56 (vs ₹4.33 in FY 2023)Full year 2024 results: EPS: ₹2.56 (down from ₹4.33 in FY 2023). Revenue: ₹562.3m (down 4.4% from FY 2023). Net income: ₹29.7m (down 41% from FY 2023). Profit margin: 5.3% (down from 8.5% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
お知らせ • May 08Resonance Specialties Limited to Report Q4, 2024 Results on May 14, 2024Resonance Specialties Limited announced that they will report Q4, 2024 results on May 14, 2024
Valuation Update With 7 Day Price Move • Apr 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹109, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.
Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: ₹0.83 (vs ₹0.75 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.83 (up from ₹0.75 in 3Q 2023). Revenue: ₹156.0m (up 69% from 3Q 2023). Net income: ₹9.61m (up 11% from 3Q 2023). Profit margin: 6.2% (down from 9.4% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 19Resonance Specialties Limited to Report Nine Months, 2024 Results on Feb 06, 2024Resonance Specialties Limited announced that they will report nine months, 2024 results on Feb 06, 2024
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹112, the stock trades at a trailing P/E ratio of 37.5x. Average trailing P/E is 30x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years.
Reported Earnings • Nov 04Second quarter 2024 earnings released: EPS: ₹0.39 (vs ₹1.24 in 2Q 2023)Second quarter 2024 results: EPS: ₹0.39 (down from ₹1.24 in 2Q 2023). Revenue: ₹103.9m (down 31% from 2Q 2023). Net income: ₹4.63m (down 66% from 2Q 2023). Profit margin: 4.5% (down from 9.1% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
お知らせ • Oct 19Resonance Specialties Limited to Report Q2, 2024 Results on Nov 03, 2023Resonance Specialties Limited announced that they will report Q2, 2024 results on Nov 03, 2023
お知らせ • Aug 30Resonance Specialties Limited Approves Appointment of Vaibhavi Rajeshirke as Company Secretary & Compliance OfficerResonance Specialties Limited announced that at its board meeting held on August 30, 2023, the Board has appointed Ms. Vaibhavi Rajeshirke as the company secretary & compliance officer and nodal officer for IEPF of the company with effect from August 30, 2023. Ms. Vaibhavi Rajeshirke, aged 29 years is a post graduate in commerce (M.COM) and is also an Associate Member of the Institute of Company Secretaries of India, Membership no ACS 72229. She has nearly 2 years experience in the field of Compliances and Company Secretarial functions.
Upcoming Dividend • Jul 25Upcoming dividend of ₹1.00 per share at 1.1% yieldEligible shareholders must have bought the stock before 01 August 2023. Payment date: 07 September 2023. Payout ratio is a comfortable 23% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%).
お知らせ • Jul 24Resonance Specialties Limited to Report Q1, 2024 Results on Aug 08, 2023Resonance Specialties Limited announced that they will report Q1, 2024 results on Aug 08, 2023
お知らせ • Jul 12Resonance Specialties Limited Recommends Dividend for the Financial Year Ended March 31, 2023, Payable on or Before August 31, 2023The Board of Resonance Specialties Limited has recommended a dividend of INR 1 per share (10%) for the financial year ended 31st March, 2023 on its equity shares of face value of INR 10 each which if sanctioned will be paid on or before August 31, 2023.
Reported Earnings • Jul 12Full year 2023 earnings released: EPS: ₹4.33 (vs ₹10.71 in FY 2022)Full year 2023 results: EPS: ₹4.33 (down from ₹10.71 in FY 2022). Revenue: ₹588.1m (down 22% from FY 2022). Net income: ₹50.0m (down 60% from FY 2022). Profit margin: 8.5% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 06Resonance Specialties Limited, Annual General Meeting, Aug 08, 2023Resonance Specialties Limited, Annual General Meeting, Aug 08, 2023, at 15:30 Indian Standard Time.
Reported Earnings • May 15Full year 2023 earnings released: EPS: ₹4.37 (vs ₹10.71 in FY 2022)Full year 2023 results: EPS: ₹4.37 (down from ₹10.71 in FY 2022). Revenue: ₹604.3m (down 20% from FY 2022). Net income: ₹50.0m (down 60% from FY 2022). Profit margin: 8.3% (down from 16% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 24% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 12Resonance Specialties Limited Proposes Dividend for the Financial Year 2022-23Resonance Specialties Limited at its board of directors meeting held on May 11, 2023 declared a dividend of INR 1 per share (10%) for the financial year 2022-23 subject to the approval of the Shareholders at the forthcoming Annual General Meeting.
Buying Opportunity • Feb 27Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be ₹129, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.7% over the last 3 years. Earnings per share has grown by 13%.
Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹0.75 (vs ₹2.51 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.75 (down from ₹2.51 in 3Q 2022). Revenue: ₹93.9m (down 46% from 3Q 2022). Net income: ₹8.70m (down 70% from 3Q 2022). Profit margin: 9.3% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 25Resonance Specialties Limited to Report Q3, 2023 Results on Feb 02, 2023Resonance Specialties Limited announced that they will report Q3, 2023 results on Feb 02, 2023
Board Change • Nov 16High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: ₹1.24 (vs ₹2.99 in 2Q 2022)Second quarter 2023 results: EPS: ₹1.24 (down from ₹2.99 in 2Q 2022). Revenue: ₹158.2m (down 14% from 2Q 2022). Net income: ₹13.8m (down 59% from 2Q 2022). Profit margin: 8.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 10+ 1 more updateResonance Specialties Limited Announces Resignation of Ashish Katariya as CEOResonance Specialties Limited announced resignation of Ashish Katariya as CEO of the Company due to personal reasons and his resignation is accepted by the Board with effect from close of business hours of the Company on 9th November, 2022.
お知らせ • Nov 02Resonance Specialties Limited to Report Q2, 2023 Results on Nov 09, 2022Resonance Specialties Limited announced that they will report Q2, 2023 results on Nov 09, 2022
Buying Opportunity • Aug 29Now 23% undervaluedOver the last 90 days, the stock is up 5.6%. The fair value is estimated to be ₹203, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 35%.
Buying Opportunity • Aug 14Now 20% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be ₹206, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 35%.
お知らせ • Aug 03Resonance Specialties Limited to Report Q1, 2023 Results on Aug 11, 2022Resonance Specialties Limited announced that they will report Q1, 2023 results on Aug 11, 2022
Board Change • Aug 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Upcoming Dividend • Jul 28Upcoming dividend of ₹1.00 per shareEligible shareholders must have bought the stock before 04 August 2022. Payment date: 09 September 2022. Payout ratio is a comfortable 9.3% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.8%). Lower than average of industry peers (0.8%).
Reported Earnings • Jul 17Full year 2022 earnings released: EPS: ₹10.64 (vs ₹9.12 in FY 2021)Full year 2022 results: EPS: ₹10.64 (up from ₹9.12 in FY 2021). Revenue: ₹771.1m (up 8.8% from FY 2021). Net income: ₹123.6m (up 17% from FY 2021). Profit margin: 16% (up from 15% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 56% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹166, the stock trades at a trailing P/E ratio of 16x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 326% over the past three years.
お知らせ • Jun 23Resonance Specialties Limited, Annual General Meeting, Aug 11, 2022Resonance Specialties Limited, Annual General Meeting, Aug 11, 2022. Agenda: To consider approval of dividend; to consider appointment of Mr. Charchit Jain as an Additional and Whole-time Director of the Company; and to consider other matters.
お知らせ • May 12+ 1 more updateResonance Specialties Limited Announces Resignation of Dwarika Agrawal as Whole-Time DirectorResonance Specialties Limited announced that at its Board Meeting held on May 11, 2022, Mr. Dwarika Agrawal has resigned as a Whole-time Director of the Company and is under Notice period.
お知らせ • May 05Resonance Specialties Limited to Report Q4, 2022 Results on May 11, 2022Resonance Specialties Limited announced that they will report Q4, 2022 results on May 11, 2022
Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Chairperson Archana Yadav is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹218, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 743% over the past three years.
Reported Earnings • Oct 28Second quarter 2022 earnings released: EPS ₹2.99 (vs ₹3.44 in 2Q 2021)The company reported a poor second quarter result with weaker earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹189.4m (down 17% from 2Q 2021). Net income: ₹33.5m (down 16% from 2Q 2021). Profit margin: 18% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has increased by 105% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 13Investor sentiment improved over the past weekAfter last week's 31% share price gain to ₹229, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 797% over the past three years.
Upcoming Dividend • Aug 11Upcoming dividend of ₹1.00 per shareEligible shareholders must have bought the stock before 18 August 2021. Payment date: 25 September 2021. Trailing yield: 0.6%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.7%).
Reported Earnings • Aug 05Full year 2021 earnings released: EPS ₹9.12 (vs ₹4.77 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹709.0m (up 24% from FY 2020). Net income: ₹105.2m (up 91% from FY 2020). Profit margin: 15% (up from 9.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has increased by 96% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 17Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹172, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 740% over the past three years.
Reported Earnings • Jun 05Full year 2021 earnings released: EPS ₹8.78 (vs ₹4.77 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹718.7m (up 25% from FY 2020). Net income: ₹105.2m (up 91% from FY 2020). Profit margin: 15% (up from 9.6% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 81% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • May 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹154, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 509% over the past three years.
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹142, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 357% over the past three years.
Reported Earnings • Feb 07Third quarter 2021 earnings released: EPS ₹2.82 (vs ₹2.09 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹187.5m (up 11% from 3Q 2020). Net income: ₹36.3m (up 50% from 3Q 2020). Profit margin: 19% (up from 14% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 03New 90-day high: ₹158The company is up 166% from its price of ₹59.35 on 05 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
お知らせ • Jan 25Resonance Specialties Limited to Report Q3, 2021 Results on Feb 05, 2021Resonance Specialties Limited announced that they will report Q3, 2021 results on Feb 05, 2021
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹154, the stock is trading at a trailing P/E ratio of 21.5x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 19x in the Chemicals industry in India. Total returns to shareholders over the past three years are 323%.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹135, the stock is trading at a trailing P/E ratio of 18.7x, up from the previous P/E ratio of 16.2x. This compares to an average P/E of 18x in the Chemicals industry in India. Total returns to shareholders over the past three years are 217%.
お知らせ • Dec 23+ 1 more updateResonance Specialties Limited Announces CEO ChangesResonance Specialties Limited at its board meeting held on December 21, 2020, announced that Dr. Atma Bandhu Gupta, Managing Director has informed the Company of his inability to continue as Managing Director and his intention to resign as Managing Director of the Company due to his pre-occupation and other personal reasons vide his letter dated December 14, 2020. Accordingly, the Board of Directors at their meeting held on December 21, 2020, have accepted his resignation as a Managing Director /Director of the Company with immediate effect. Mr. Ashish Katariya, Executive Director of the Company is appointed as the CEO of the Company. .
Valuation Update With 7 Day Price Move • Dec 15Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹105, the stock is trading at a trailing P/E ratio of 14.7x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 245%.
Is New 90 Day High Low • Dec 15New 90-day high: ₹105The company is up 72% from its price of ₹61.15 on 15 September 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
お知らせ • Nov 20Resonance Specialties Limited Announces Board ChangesResonance Specialties Limited announced that the appointment of Mr. Raj Kamal Prasad Verma as an Additional Director (Non-Executive & Independent), on the board of directors of Resonance Specialties Limited, it has been resolved to reconstitute Audit Committee of the Company and accordingly the Board of Directors of the Company vide Circular resolution dated November 18, 2020, have approved and reconstituted the following Committees of the Board with immediate effect: The audit committee is appointed Ms. Archana Surendra Yadav as chairman, Mr. Raj Kamal Prasad Verma, Mr. Bishwanath Prasad Agrawal and Mr. Ajay Patadia as members. The nomination and remuneration committee is appointed Mr. Raj Kamal Prasad Verma as chairman, Ms. Archana Surendra Yadav, Mr. Bishwanath Prasad Agrawal and Mr. Ajay Patadia as members. Stakeholders Relationship Committee is appointed Mr. Bishwanath Prasad Agrawal as chairman, Ms. Archana Surendra Yadav, Mr. Atma Bandhu Gupta and Mr. Raj Kamal Prasad Verma as members. Corporate Social Responsibility Committee is appointed Mr. Atma Bandhu Gupta as chairman, Mr. Bishwanath Prasad Agrawal, Ms. Archana Surendra Yadav and Mr. Raj Kamal Prasad Verma as members.
Reported Earnings • Nov 13Second quarter 2021 earnings released: EPS ₹3.44The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹227.6m (up 68% from 2Q 2020). Net income: ₹39.8m (up 254% from 2Q 2020). Profit margin: 18% (up from 8.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 18% share price gain to ₹69.85, the stock is trading at a trailing P/E ratio of 15x, up from the previous P/E ratio of 12.7x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 129%.
Is New 90 Day High Low • Nov 12New 90-day high: ₹69.85The company is up 49% from its price of ₹46.80 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
お知らせ • Sep 09Resonance Specialties Limited to Report Q1, 2021 Results on Sep 15, 2020Resonance Specialties Limited announced that they will report Q1, 2021 results on Sep 15, 2020
お知らせ • Aug 08Resonance Specialties Limited Expects to Full Plant Operations in Couple of MonthsResonance Specialties Limited announced that due to COVID-19 outbreak and as per directives issued by the Government of India, State Governments and other regulatory authorities, the company had temporarily suspended manufacturing in company's Plant. Operations were partially resumed and full resumption is expected in next couple of months. The Company has also Implemented Work from Home Policy for its employees to ensure compliance with Government's directives and to safeguard employee's health and safety.
お知らせ • Jul 05Resonance Specialties Limited to Report Q4, 2020 Results on Jul 31, 2020Resonance Specialties Limited announced that they will report Q4, 2020 results on Jul 31, 2020
